No Detail Found!

Impact of MLL::AF9 Gene Rearrangement on Survival of Acute Myeloid Leukaemia Patients: An Insight into Pakistani Population

Author(s)
Muhammad Tariq Department of Forensic Medicine and Toxicology, Saidu Medical College, Swat, Pakistan; Department of Haematology, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan
Sadaf Shahab Department of Haematology, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan
Javeria Rauf Saeed Department of Pathology, Saidu Medical College, Swat, Pakistan
Zeeshan Hussain Department of Pathology, Hamdard University, Karachi, Pakistan
Uzma Zaidi Department of Haematology, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan
Tasneem Farzana Department of Haematology, National Institute of Blood Diseases and Bone Marrow Transplantation,Karachi,Pakistan
Sultan Ahmad Regional Blood Centre, Saidu Sharif, Swat, Pakistan
Abstract
Objective: To ascertain the frequency of the MLL::AF9 gene rearrangement and its association with survival in Pakistani patients su ering from acute myeloid leukaemia (AML). Study Design: Analytical study. Place and Duration of the Study: Department of Haematology, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan, from 2015 to 2020. Methodology: Patients without a history of past AML chemotherapy, aged from 10 to 75 years, were included. Individuals with metastatic cancer, chronic myeloid leukaemia, or other haematological conditions were excluded. Identifying the MLL::AF9 gene involved RNA extraction, cDNA synthesis, and Real-time PCR ampli cation. The Chi-square test was used to examine the relationship between survival and the MLL::AF9 mutation. A Welch two-sample t-test was used to evaluate survival days depending on the MLL::AF9 gene rearrangement, while ANOVA was used to analyse survival days across various death statuses. Results: The mean age of 130 patients was 36.65 ± 13.01 years, with 64.62% being males. The most common leukaemia type was AML-M2 (n = 32, 24.62%). During the study follow-up, 22.31% were still alive, 40.77% died, and the status of 36.92% were unknown. MLL::AF9 gene rearrangement was present in 11.54%. The group with MLL::AF9 gene rearrangement had signi cantly longer mean survival days (1,542.33 ± 926.07) compared to the group without the gene rearrangement (206.42 ± 359.57, p <0.001). Conclusion: MLL-AF9 mutation was present in 11.54%. Age and MLL::AF9 gene rearrangement were signi cant predictors of survival in leukaemia patients.
Publication Details
Page(s) 424-428
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 34, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
survival, Acute myeloid leukaemia, Gene rearrangement
0

Citations

0

Downloads

106

Views